A Reproducible Strategy for Analisis of Minimal Residual Disease Measured by Standarized Multiparametric Flow Cytometry in B Acute Lymphoblastic Leukemia

Cytometry Part B - Clinical Cytometry - United States
doi 10.1002/cyto.b.21720